BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27475789)

  • 1. Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis.
    Flokas ME; Detsis M; Alevizakos M; Mylonakis E
    J Infect; 2016 Dec; 73(6):547-557. PubMed ID: 27475789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis.
    Alevizakos M; Nasioudis D; Mylonakis E
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28803446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence.
    Pilmis B; Scemla A; Join-Lambert O; Mamzer MF; Lortholary O; Legendre C; Zahar JR
    Infect Dis (Lond); 2015; 47(10):714-8. PubMed ID: 26024285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-Analysis.
    Flokas ME; Karanika S; Alevizakos M; Mylonakis E
    PLoS One; 2017; 12(1):e0171216. PubMed ID: 28141845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
    Madhi F; Jung C; Timsit S; Levy C; Biscardi S; Lorrot M; Grimprel E; Hees L; Craiu I; Galerne A; Dubos F; Cixous E; Hentgen V; Béchet S; ; Bonacorsi S; Cohen R
    PLoS One; 2018; 13(1):e0190910. PubMed ID: 29370234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
    Ndir A; Diop A; Faye PM; Cissé MF; Ndoye B; Astagneau P
    PLoS One; 2016; 11(2):e0143729. PubMed ID: 26867226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
    Lagree M; Bontemps S; Dessein R; Angoulvant F; Madhi F; Martinot A; Cohen R; Dubos F;
    Med Mal Infect; 2018 May; 48(3):193-201. PubMed ID: 29449049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
    Dalgic N; Sancar M; Bayraktar B; Dincer E; Pelit S
    Scand J Infect Dis; 2011 May; 43(5):339-43. PubMed ID: 21271945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis.
    Alevizakos M; Karanika S; Detsis M; Mylonakis E
    Int J Antimicrob Agents; 2016 Dec; 48(6):647-654. PubMed ID: 27746102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria.
    Briongos-Figuero LS; Gómez-Traveso T; Bachiller-Luque P; Domínguez-Gil González M; Gómez-Nieto A; Palacios-Martín T; González-Sagrado M; Dueñas-Laita A; Pérez-Castrillón JL
    Int J Clin Pract; 2012 Sep; 66(9):891-6. PubMed ID: 22897466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital.
    Strysko JP; Mony V; Cleveland J; Siddiqui H; Homel P; Gagliardo C
    Travel Med Infect Dis; 2016; 14(6):568-571. PubMed ID: 27890813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.
    Dayan N; Dabbah H; Weissman I; Aga I; Even L; Glikman D
    J Pediatr; 2013 Nov; 163(5):1417-21. PubMed ID: 23919903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis.
    Alevizakos M; Gaitanidis A; Andreatos N; Arunachalam K; Flokas ME; Mylonakis E
    Int J Antimicrob Agents; 2017 Nov; 50(5):657-663. PubMed ID: 28705665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram.
    García-Tello A; Gimbernat H; Redondo C; Meilán E; Arana DM; Cacho J; Dorado JF; Angulo JC
    Scand J Urol; 2018 Feb; 52(1):70-75. PubMed ID: 28893132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia.
    Abera B; Kibret M; Mulu W
    PLoS One; 2016; 11(11):e0166519. PubMed ID: 27846254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Febrile Urinary Tract Infection Caused by ESBL Producing
    Agegnehu A; Worku M; Nigussie D; Lulu B; Tadesse BT
    Biomed Res Int; 2020; 2020():6679029. PubMed ID: 34692824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-spectrum β-lactamase-producing bacteria causing community-acquired urinary tract infections in children.
    Megged O
    Pediatr Nephrol; 2014 Sep; 29(9):1583-7. PubMed ID: 24705795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
    Raja NS
    J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.